近日据美国圣路易斯华盛顿大学医学院的研究者公开宣称,他们认为β_2肾上腺素能激动剂特布他林可用于预防1型糖尿病患者出现夜间低血糖。据了解,特布他林为选择性的β_2受体激动剂,具有扩张支气管的作用,临床常用于治疗支气管哮喘、喘息性支气管炎、肺气肿等疾病。 Recently, researchers at the Washington University School of Medicine in St. Louis announced publicly that they think terbutaline, a beta 2 adrenergic agonist, can be used to prevent nocturnal hypoglycemia in people with type 1 diabetes. It is understood that terbutaline is a selective β 2 receptor agonist, with the expansion of the role of bronchial, clinically used in the treatment of bronchial asthma, asthmatic bronchitis, emphysema and other diseases.